BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 22820620)

  • 1. Association between family history of prostate cancer and positive biopsies in a Brazilian screening program.
    Muller RL; Faria EF; Carvalhal GF; Reis RB; Mauad EC; Carvalho AL; Freedland SJ
    World J Urol; 2013 Oct; 31(5):1273-8. PubMed ID: 22820620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital Rectal Examination Is Not a Useful Screening Test for Prostate Cancer.
    Krilaviciute A; Becker N; Lakes J; Radtke JP; Kuczyk M; Peters I; Harke NN; Debus J; Koerber SA; Herkommer K; Gschwend JE; Meissner VH; Benner A; Seibold P; Kristiansen G; Hadaschik B; Arsov C; Schimmöller L; Giesel FL; Antoch G; Makowski M; Wacker F; Schlemmer HP; Kaaks R; Albers P
    Eur Urol Oncol; 2023 Dec; 6(6):566-573. PubMed ID: 37806841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A west African ancestry-associated SNP on 8q24 predicts a positive biopsy in African American men with suspected prostate cancer following PSA screening.
    Gu J; Chery L; González GMN; Huff C; Strom S; Jones JA; Griffith DP; Canfield SE; Wang X; Huang X; Roberson P; Meng QH; Troncoso P; Ittmann M; Covinsky M; Scheurer M; Irizarry Ramirez M; Pettaway CA
    Prostate; 2024 May; 84(7):694-705. PubMed ID: 38477020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-cohort modeling strategies for scalable globally accessible prostate cancer risk tools.
    Tolksdorf J; Kattan MW; Boorjian SA; Freedland SJ; Saba K; Poyet C; Guerrios L; De Hoedt A; Liss MA; Leach RJ; Hernandez J; Vertosick E; Vickers AJ; Ankerst DP
    BMC Med Res Methodol; 2019 Oct; 19(1):191. PubMed ID: 31615451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Community-Based Prostate Cancer Screening and Education Program for Asian American Men in Medically Underserved Communities.
    Cho D; Gor B; Hwang H; Wang X; Hernandez M; Jones LA; Frost J; Roberson P; Pettaway CA
    Int J Environ Res Public Health; 2024 Mar; 21(4):. PubMed ID: 38673327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Active Surveillance an Option for the Management of Men with Low-grade Prostate Cancer and a Positive Family History? Results from a Large, Single-institution Series.
    Leni R; Gandaglia G; Stabile A; Mazzone E; Pellegrino F; Scuderi S; Robesti D; Barletta F; Cirulli GO; Cucchiara V; Zaffuto E; Dehò F; Montorsi F; Briganti A
    Eur Urol Oncol; 2023 Oct; 6(5):493-500. PubMed ID: 37005213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening history and risk of death from prostate cancer: a nested case-control study within the screening arm of the Finnish Randomized Study of Screening for Prostate Cancer (FinRSPC).
    Talala K; Walter S; Taari K; Tammela TLJ; Kujala P; Auvinen A
    Cancer Causes Control; 2024 Apr; 35(4):695-703. PubMed ID: 38063980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate specific antigen test uptake: a cross sectional study on elderly men in Western Iran.
    Mirzaei-Alavijeh M; Jalilian F; Solaimanizadeh L; Saadatfar A; Khashij S; Pirouzeh R; Solaimanizadeh F
    BMC Geriatr; 2020 Aug; 20(1):298. PubMed ID: 32831024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review.
    Bergengren O; Pekala KR; Matsoukas K; Fainberg J; Mungovan SF; Bratt O; Bray F; Brawley O; Luckenbaugh AN; Mucci L; Morgan TM; Carlsson SV
    Eur Urol; 2023 Aug; 84(2):191-206. PubMed ID: 37202314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer knowledge and barriers to screening among men at risk in northern Tanzania: A community-based study.
    Ngowi BN; Mremi A; Mbwambo OJ; Mitao MP; Nyindo M; Mteta KA; Mmbaga BT
    Cancer Treat Res Commun; 2024; 39():100811. PubMed ID: 38574439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial finds that prostate cancer genetic risk score feedback targets prostate-specific antigen screening among at-risk men.
    Turner AR; Lane BR; Rogers D; Lipkus I; Weaver K; Danhauer SC; Zhang Z; Hsu FC; Noyes SL; Adams T; Toriello H; Monroe T; McKanna T; Young T; Rodarmer R; Kahnoski RJ; Tourojman M; Kader AK; Zheng SL; Baer W; Xu J
    Cancer; 2016 Nov; 122(22):3564-3575. PubMed ID: 27433786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finding the PSA-based screening stopping age using prostate cancer risk.
    Nahvijou A; Hadian M; Mohamadkhani N
    Cancer Treat Res Commun; 2024; 38():100791. PubMed ID: 38266550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global viewpoints: updates on prostate cancer in Sub-Saharan Africa.
    Jalloh M; Cassell A; Niang L; Rebbeck T
    BJU Int; 2024 Jan; 133(1):6-13. PubMed ID: 37702258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Influencing Uptake of Prostate Cancer Screening among Men Aged 40 Years and Above in Kazo Town Council, Kazo District, Uganda: A Cross-Sectional Study.
    Mwebembezi S; Alege JB; Nakaggwa F; Nanyonga RC
    Biomed Res Int; 2023; 2023():7770943. PubMed ID: 38170054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatin conformation changes in peripheral blood can detect prostate cancer and stratify disease risk groups.
    Alshaker H; Mills R; Hunter E; Salter M; Ramadass A; Skinner BM; Westra W; Green J; Akoulitchev A; Winkler M; Pchejetski D
    J Transl Med; 2021 Jan; 19(1):46. PubMed ID: 33509203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of podcasts to provide public education on prostate cancer genetics.
    Loeb S; Sanchez Nolasco T; Siu K; Byrne N; Giri VN
    Prostate Cancer Prostatic Dis; 2023 Dec; 26(4):772-777. PubMed ID: 36681741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early prediction of prostate cancer risk in younger men using polygenic risk scores and electronic health records.
    Varma A; Maharjan J; Garikipati A; Hurtado M; Shokouhi S; Mao Q
    Cancer Med; 2023 Jan; 12(1):379-386. PubMed ID: 35751453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of cancer family history and genetic counseling eligibility among African Americans with breast, prostate, lung, and colorectal cancers: A Detroit Research on Cancer Survivors cohort study.
    Purrington KS; Schwartz AG; Ruterbusch JJ; Manning MA; Nair M; Wenzlaff AS; Pandolfi SS; Simon MS; Beebe-Dimmer J
    Cancer; 2020 Nov; 126(21):4744-4752. PubMed ID: 32749684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological description and trajectories of patients with prostate cancer in Denmark: an observational study of 7448 patients.
    Blanes-Vidal V; Tashk A; Cantuaria ML; Hansen RS; Poulsen CA; Poulsen MH; Krogh ML; Sheikh SP; Nadimi ES
    BMC Res Notes; 2023 Nov; 16(1):341. PubMed ID: 37974202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthy lifestyle and prostate cancer risk in the Million Veteran Program.
    Pagadala MS; Lui A; Lynch J; Karunamuni R; Lee KM; Plym A; Rose BS; Carter H; Kibel AS; DuVall SL; Vassy J; Gaziano JM; Panizzon MS; Hauger RL; Seibert TM
    Cancer; 2024 Jun; ():. PubMed ID: 38865417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.